Cite
HARVARD Citation
Altunoren, O. et al. (2020). Can vasohibin‐1, an endothelium‐derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?. Seminars in dialysis. 33 (5), pp. 418-427. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Altunoren, O. et al. (2020). Can vasohibin‐1, an endothelium‐derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?. Seminars in dialysis. 33 (5), pp. 418-427. [Online].